Related Experiment Video
Updated: Feb 22, 2026
10:46
Diffusion Imaging in the Rat Cervical Spinal Cord
Published on: April 7, 2015
12.3K
Whole-body diffusion-weighted imaging in lymphoma.
1Department of Radiology, Centre Hospitalo-Universitaire Henri Mondor, Avenue du Marechal de Lattre de Tassigny, Créteil, France.
Summary
Whole-body diffusion-weighted magnetic resonance imaging (DWI) shows promise as a valuable tool for lymphoma staging and clinical decision-making. Further large-scale studies are required to confirm these preliminary findings and establish its role in oncology.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Whole-body diffusion-weighted magnetic resonance imaging (DWI) integrates anatomical and functional data.
- Its utility in oncology is growing, particularly for cancer staging.
- Lymphoma diagnosis and management can benefit from advanced imaging techniques.
Purpose of the Study:
- To review the current evidence on the effectiveness of whole-body DWI in lymphoma.
- To assess the potential of DWI as a biomarker in lymphoma patient care.
- To identify the need for further research in this area.
Main Methods:
- Literature review of existing studies on whole-body DWI in lymphoma.
- Analysis of DWI's capability to provide both anatomical and functional information.
- Evaluation of DWI's role in oncology, specifically for staging.
Main Results:
- Preliminary results suggest DWI is a valuable tool in oncology.
- DWI shows potential as a useful biomarker for clinical decision-making in lymphoma patients.
- Current evidence indicates DWI's promise in lymphoma management.
Conclusions:
- Whole-body DWI is a promising imaging modality for lymphoma.
- Further large-scale prospective studies are necessary to validate these findings.
- DWI may significantly impact clinical decision-making for lymphoma patients.
